Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 951-975 of 2,022
CompletedNCT03235908

Copeptin in Outcome Prediction of an Acute Psychotic Episode

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Switzerland
Sponsor
University Hospital, Basel, Switzerland
Condition
Schizophrenia
TerminatedNCT03257592

Positron Emission Tomography (PET) Imaging of Glial Activation in Psychotic Disease States

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Schizophrenia
CompletedNCT03854409

A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolarity I

This study exists to explore whether the medication Single could improve care and understanding. Researchers are trying to understand what the medication Single could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
CompletedNCT03872596

Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolarity

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
CompletedNCT03338673

Brain Stimulation and Cognitive Training

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of Michigan
Condition
Schizophrenia
CompletedNCT03028545

Representations and Strategies for Recovery

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 80 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
TerminatedNCT01624831

Social Cognition in Longstanding Psychosis

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
United States
Sponsor
University of Arizona
Condition
Schizophrenia
CompletedNCT01570972

Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis

This study exists to explore whether cognitive behavioural therapy, a structured talking treatment, could improve care and understanding. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
University of Arizona
Condition
Schizophrenia
CompletedNCT01196286

Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis

This study exists to explore whether psychoeducation, a guided learning and support program, could improve care and understanding. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
University of Arizona
Condition
Schizophrenia
CompletedNCT01329393

Benefits Management for People With Psychiatric Disabilities

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
CompletedNCT04325100

Intervention Targeting Motivational Negative Symptoms

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 65 Years
Countries
Belgium
Sponsor
University of Liege
Condition
Depression
CompletedNCT02097563

Family-Focused Therapy for Youth With Early-Onset Bipolar or Psychotic Disorders

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 13 Years to 25 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
CompletedNCT01914393

Pediatric Open-Label Extension Study

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherFrom 6 Years to 17 Years
Countries
Bulgaria, Colombia, France, Hungary, Malaysia, Mexico, Philippines, Poland, United States, Romania, Russian Federation, South Korea, Spain, Ukraine
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
TerminatedNCT00001260

Brain Tissue Collection for Neuropathological Studies

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOther
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Schizophrenia
CompletedNCT01804582

The Family VOICE Study

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

BipolarityOtherFrom 2 Years to 15 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Bipolarity
TerminatedNCT03643159

A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolarity type I, and Major Depressive Disorder

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

DepressionOtherFrom 18 Years to 63 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Depression
CompletedNCT02451670

Reducing Cardiovascular Risk in Adults With Serious Mental Illness

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand what smoking support or smoking-related treatment can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
United States
Sponsor
HealthPartners Institute
Condition
Schizophrenia
CompletedNCT02218853

Psychosis and Affective Research Domains and Intermediate Phenotypes

This study exists to improve how blood tests and biological markers can help identify, measure, or follow care over time. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Schizophrenia
TerminatedNCT03092687

Procedures for Sample Acquisition and Distribution for The Human Brain Collection Core

This study exists to improve how a digital app or remote support tool can help identify, measure, or follow care over time. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherUp to 120 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Schizophrenia
CompletedNCT00585273

Antipsychotics and Blood Vessel Function

This study exists to understand how smoking support or smoking-related treatment holds up over time after the earliest research stage. Researchers are trying to understand whether smoking support or smoking-related treatment can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
Jess G. Fiedorowicz
Condition
Schizophrenia
CompletedNCT02035202

Real-Time Mobile Cognitive Behavioral Intervention for Serious Mental Illness

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
CompletedNCT03656770

Measuring Beliefs and Norms About Persons With Mental Illness

This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand whether questionnaires and follow-up reports can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherOver 18 Years
Countries
Uganda
Sponsor
Massachusetts General Hospital
Condition
Schizophrenia